Materias dentro de su búsqueda.
Mostrando 1,281 - 1,300 Resultados de 58,773 Para Buscar '"Her"', tiempo de consulta: 0.68s Limitar resultados
  1. 1281
    “…There was no relationship between a mother's knowledge related to health benefits, organoleptic properties and cooking technique-related attitude toward fish and her child's fish consumption. CONCLUSIONS: The fish consumption of children is not influenced by their mother's perspective on fish. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A mothers' perspective on fish and her child's fish consumption in Surakarta, Indonesia
  2. 1282
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
  3. 1283
    “…Trastuzumab has, nonetheless, revolutionized HER2+ breast cancer treatment, and several HER2-directed mAbs have been developed using Fc glyco-engineering or Fc protein-engineering to enhance FcγR-mediated functions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Role of Fcγ receptors in HER2-targeted breast cancer therapy
  4. 1284
    “…Anti-HER2-directed agents represent the mainstay of treatment of patients with HER2-positive metastatic breast cancer (MBC). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    How we treat patients with metastatic HER2-positive breast cancer
  5. 1285
    “…HER2+ breast cancer (BC) is an aggressive subtype representing a genetically and biologically heterogeneous group of tumors resulting in variable prognosis and treatment response to HER2-targeted therapies according to estrogen (ER) and progesterone receptor (PR) expression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes
  6. 1286
    “…Breast cancer is characterized by the uncontrolled proliferation of breast epithelial cells under the action of a variety of carcinogens. Although HER2-inhibitors were currently applied for HER2-positive breast cancer patients, they didn’t work for patients with resistance to HER2-targeted anti-cancer drugs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    CuS@BSA-NB2 Nanoparticles for HER2-Targeted Photothermal Therapy
  7. 1287
    “…We evaluated serum samples obtained at diagnosis from 249 case:control pairs with stage II-III Her2-negative breast cancer with or without subsequent distant recurrence. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer
  8. 1288
    “…Owing to overexpression in a wide range of tumors, human epidermal growth factor receptor 2 (Her2) is one of the most utilized targeting antigens for ADCs to treat Her2-positive cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Novel development strategies and challenges for anti-Her2 antibody-drug conjugates
  9. 1289
    “…Amongst the different BC subtypes, human epidermal growth factor receptor 2 (HER2)-positive tumours are characterised by an overexpression of the HER2 membrane receptor. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Unveiling the Potential of Liquid Biopsy in HER2-Positive Breast Cancer Management
  10. 1290
    “…Human epidermal growth factor receptor 2 (HER2) is a transmembrane glycoprotein receptor with intracellular tyrosine kinase activity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Consensus for HER2 alterations testing in non-small-cell lung cancer
  11. 1291
    “…SIMPLE SUMMARY: Trastuzumab and radiation are used clinically to treat HER2-overexpressing breast cancers; however, the mechanistic synergy of anti-HER2 and radiation therapy has not been investigated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast Cancer
  12. 1292
    “…HER2 aberrations have been reported as a novel biomarker in HER2-directed therapy or as a prognostic marker in various tumor types. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer
  13. 1293
    “…Here, we report the case of a 56-year-old female with human epidermal growth factor receptor 2 (HER2) expression (IHC 2+/FISH-) in gastric cancer with systemic metastasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH- Gastric Cancer
  14. 1294
    por Lebert, Julie, Lilly, Evan J.
    Publicado 2022
    “…Approximately 20% of breast cancers overexpress human epidermal growth factor receptor 2 (HER2), providing an actionable target for many different therapies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Developments in the Management of Metastatic HER2-Positive Breast Cancer: A Review
  15. 1295
    “…In contrast to n-type conductivity in pristine Cd(7)P(4)Cl(6), Mn(2+) substituted Cd(7−y)Mn(y)P(4)Cl(6) analogues exhibit p-type conductivity with a remarkable enhancement in the photochemical HER activity and stability of the system. Photochemical properties of pristine and substituted compounds are explained by studying the nature of charge carriers and their dynamics.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of Mn(2+) substitution on the structure, properties and HER activity of cadmium phosphochlorides
  16. 1296
    “…Background  Bladder cancer is a common urological cancer. Her-2 gene is a proto-oncogene which is present in 17q12 chromosomal region. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Overexpression of Her-2 in Biopsy-Proven Urothelial Carcinoma Patients From Pakistan
  17. 1297
    por Harbeck, Nadia
    Publicado 2022
    “…The availability of HER2-targeted therapy has dramatically improved patient outcome in HER2-positive (HER2+) early breast cancer (EBC) as recently demonstrated by the EBCTCTG metaanalysis on trastuzumab in HER2+ EBC: Adding trastuzumab to chemotherapy has reduced recurrence rates and breast-cancer related mortality by a third [1]. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer()
  18. 1298
    “…SIMPLE SUMMARY: Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a heterogeneous disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives
  19. 1299
    “…The conjugation was mediated by the PEG linker to obtain Ag-PEG-HER2 nanoparticles. Flow cytometry tests showed that Ag-PEG-HER2 particles successfully bind to HER2-overexpressing cells with a specificity comparable to that of full-size anti-HER2 IgGs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission
  20. 1300
    por Hasan, Menna M., Allam, Nageh K.
    Publicado 2022
    “…Electrochemical hydrogen evolution reaction (HER) is typically studied in three-electrode system. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An alternative, low-dissolution counter electrode to prevent deceptive enhancement of HER overpotential
Herramientas de búsqueda: RSS